Given the crucial importance of AR in all stages of prostate cancer progression and the paucity of data on the outcomes of mutations, we have undertaken a comprehensive study of 45 mutations which span the entire length of the protein and are predominantly associated with high Gleason scores and metastatic tumors. Here, AR is linked to metastatic neoplasm.